• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jubilant Pharmova Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Jubilant Bhartia
  • BSE Code : 592.0
  • ISIN : INE700A01033
1,070.85 22 (2.06%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    1,045.40

  • Today’s High

    1,079.05

  • Open

    1,052.60

  • Perv Close

    1,049.25

  • 52W Low

    786.05

  • 52W High

    1,184.80

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    17,058.64

  • Div & Yield %

    0.47

  • Book Value(₹)

    145.16

  • Debt-Equity Ratio

    2.06

  • AGM Date

    22-Sep-2026

  • EPS

    1.98

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.68

  • Mar.Cap (₹Cr.)

    17,058.64

  • RONW (%)

    0.76

  • ROCE (%)

    6.37

Score Board

  • Equity (₹ in Cr.)

    15.93

  • BV (₹)

    145.20

  • Sales( ₹ in Cr.)

    263.50

  • NP (in Cr.)

    70.84

  • NP Var(%)

    219.0

  • Div%

    500.0

  • CPS (₹)

    4.80

  • EPS (₹)

    4.40

  • Traded Value (₹ in Lakhs)

    17,057.84

  • 52 Week High

    1,184.80

  • 52 Week Low

    786.05

  • Price BSE

    1071.0

  • Price NSE

    1,071.00

  • Market Capital( in Cr.)

    17,057.84

  • P/C Ratio

    222.00

  • P/E Ratio

    240.80

  • Price Vs.BV

    4.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 263.50 231.40 784.70 810.10 725.73 2,709.50
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 263.50 231.40 784.70 810.10 725.73 2,709.50
Other Income 45.70 20.20 103.40 137.90 126.16 47.88
Stock Adjustments 0.00 0.00 -39.00 -3.50 40.61 -55.21
Total Income 309.20 251.60 849.10 944.50 892.50 2,702.17
EXPENDITURE :            
Raw Materials 0.00 0.00 316.50 411.10 372.89 1,395.15
Power and Fuel Cost 26.20 23.70 68.40 75.40 62.31 280.40
Employee Cost 103.80 92.10 190.00 167.30 163.64 220.67
Other Manufacturing Expenses 25.60 22.80 59.60 49.00 39.80 216.91
Selling and Administration Expenses 55.40 48.60 88.60 93.00 111.59 100.02
Miscellaneous Expenses 12.40 6.50 6.10 7.70 9.65 14.07
Employee Benefit Expenses 103.80 92.10 190.00 167.30 163.64 220.67
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 223.40 193.70 729.20 803.50 759.88 2,227.23
Operating Profit 85.80 57.90 119.90 141.00 132.62 474.94
Interest 7.30 12.90 29.90 18.50 10.99 101.80
Gross Profit 78.50 45.00 90.00 122.50 121.63 373.14
Depreciation 6.00 6.60 48.30 43.20 36.91 99.97
Profit Before Tax 72.50 38.40 41.70 79.30 84.72 273.17
Current Tax 4.60 20.50 6.80 13.80 14.28 45.44
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.70 -1.30 3.30 15.60 -10.05 13.25
Reported Net Profit 63.20 19.20 31.60 49.90 80.49 214.48
Extraordinary Items -7.64 -3.00 -0.76 0.25 0.02 -0.19
Adjusted Net Profit 70.84 22.20 32.36 49.65 80.47 214.67
Adjustment below Net Profit 5.40 3.30 0.00 -0.70 0.81 -212.82
P & L Balance brought forward 1,018.50 1,075.60 1,123.60 1,154.00 1,152.37 1,153.26
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 79.60 79.60 79.60 79.60 79.64 0.00
P & L Balance carried down 1,007.50 1,018.50 1,075.60 1,123.60 1,154.03 1,154.92
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 500.00 500.00 500.00 500.00 500.00 500.00
Dividend Per Share(Rs) 5.00 5.00 5.00 5.00 5.00 5.00
Earnings Per Share-Unit Curr 3.97 1.21 1.99 3.14 5.05 13.46
Earnings Per Share(Adj)-Unit Curr 3.97 1.21 1.99 3.14 5.05 13.46
Book Value 145.43 145.79 149.34 151.86 153.11 80.51
Book Value(Adj)-Unit Curr 145.43 145.79 149.34 151.86 153.11 80.51

Shareholding Pattern

  • Promoter Group

    47.68%

  • Public Share Holding

    51.77%

  • Custodian

    0.55%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 5,230,455 3.28 5,230,455 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 5,000 5,000.00 5,000 5,000
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 5,235,455 3.29 5,235,455 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 68,804,742 43.20 68,804,742 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,898,425 1.19 1,898,425 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 70,703,167 44.39 70,703,167 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,645 0.00 2,045 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 25,280,499 15.87 25,280,499 146
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,791,940 1.13 1,791,940 2
Mutual Funds / UTI 14,326,627 8.99 14,326,627 23
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,628,501 2.28 3,628,501 14
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 45,030,212 28.27 45,029,612 187
2] Non Institution
Bodies Corporate 4,971,542 3.12 4,971,542 695
Clearing Members 148,914 0.09 148,914 24
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,933,070 1.21 1,912,055 2,527
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 581,787 0.37 581,787 1,387
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,244,000 6.43 10,244,000 2
Individuals holding nominal share capital up to Rs. 1 lakh 17,088,028 10.73 16,781,008 77,767
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 19,032 0.01 19,032 8
Others 1,989,722 1.25 1,989,722 1
Sub Total 37,433,704 23.50 37,105,669 82,504
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 878,601 0.55 878,601 1
Total Shares held by Custodians and against which Depository Receipts have been issued 878,601 0.55 878,601 1
Grand Total ( A + B + C ) 159,281,139 100.00 158,952,504 82,703

Company Background

Jubilant Pharmova LtdPharmaceuticals - Indian - Bulk Drugs

  • Jubilant Pharmova Ltd
  • BSE Code : 592.0
  • ISIN : INE700A01033

  • Incorporation Year

    1978

  • Registered Office

    Bhartiagram Gajraula
    , Amroha,
    Uttar Pradesh-244223

  • Telephone

    91-5924-267200

  • FAX

    91-5924-4264895/96

  • Chairman

    Shyam S Bhartia

  • Managing Director

  • Company Secretary

    Naresh Kapoor

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    Alankit Heights ,
    1E/13 Jhandewalan Ex,
    Mumbai - New Delhi-110055

Jubilant Pharmova Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jubilant Pharmo 1,070.80 265.90 263.50 263.74 1.79
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77